IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau ##### Up next ![South Asian University (SAU), New Delhi Expands Academic Offerings and Opens Admissions for 2025-26](https://i0.wp.com/r2.thailandbusinessnews.net/2025/03/SAU_admissions_2025_26.jpg?resize=200%2C110&ssl=1 "South Asian University (SAU), New Delhi Expands Academic Offerings and Opens Admissions for 2025-26") [](https://thailandbusinessnews.net/press-release/south-asian-university-sau-new-delhi-expands-academic-offerings-and-opens-admissions-for-2025-26/) ###### [South Asian University (SAU), New Delhi Expands Academic Offerings and Opens Admissions for 2025-26](https://thailandbusinessnews.net/press-release/south-asian-university-sau-new-delhi-expands-academic-offerings-and-opens-admissions-for-2025-26/) Published on 28 March 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ — IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the Pharmaceutical Administration Bureau of the Macao Special Administrative Region (ISAF) has approved the New Drug Application (NDA) for Equecabtagene Autoleucel. This treatment is indicated for adult patients with relapsed or refractory multiple myeloma (R/RMM) who have received three or more lines of prior therapies, including at least one proteasome inhibitor and an immunomodulatory agent. This is the first NDA approval for Equecabtagene Autoleucel outside Mainland China. Equecabtagene Autoleucel (trade name: FUCASO) was approved by China’s National Medical Products Administration (NMPA) on June 30, 2023, for treating adult patients with relapsed or refractory multiple myeloma (R/RMM) who have received three or more lines of prior therapies, including at least one proteasome inhibitor and an immunomodulatory agent. On January 29 and February 14, 2025, the NDA for this product for the above indications was formally accepted by the Health Sciences Authority of Singapore and the Department of Health of Hong Kong, China, respectively. The Macau NDA approval is based on data from the pivotal FUMANBA-1 trial (CTR20192510, NCT05066646), a China-based, multi-site, Phase I/II registrational study evaluating the efficacy and safety of equecabtagene autoleucel in patients with relapsed/refractory multiple myeloma (R/R MM). The results demonstrated that equecabtagene autoleucel achieves outstanding efficacy and a favorable safety profile. Ms. Zhang Jinhua, Founder, Chairperson, and CEO of IASO Biotherapeutics, stated: "We are delighted that the New Drug Application (NDA) for equecabtagene autoleucel has been approved by the Macau Drug Administration—the product’s first NDA approval outside Mainland China, marking a significant milestone. Through our innovative ‘Manufactured in Nanjing, Supplied Globally’ model, we will ensure timely access to this CAR-T therapy for multiple myeloma patients in Macau. In December last year, we successfully delivered our Nanjing-manufactured CAR-T therapy to patients in Hong Kong through the Named Patient Program (NPP). Subsequently, in January and February of this year, the NDAs for equecabtagene autoleucel were officially accepted by the Singapore Health Sciences Authority and the Hong Kong Department of Health, respectively. We are actively collaborating with regulatory authorities to advance the approval processes and look forward to delivering clinical benefits to patients in these regions at the earliest opportunity. Meanwhile, IASO Bio remains committed to expanding the global footprint of our CAR-T therapies, dedicated to providing more treatment options for multiple myeloma patients worldwide." About Multiple Myeloma（MM) Multiple myeloma (MM) is the second most common hematological malignancy globally. According to Globocan data, the global incidence of multiple myeloma in 2022 was 1.8 per 100,000 people, with a 5-year prevalence of 6.8 per 100,000. Despite progress in current anti-myeloma treatments, MM remains largely incurable with multiple relapses and tendency to develop refractoriness to several drug classes, presenting a major therapeutic challenge. Thus, there is an unmet need for new treatment options beyond these current anti-myeloma therapies for the treatment of relapsed or refractory MM, capable of achieving deep and durable responses. About Equecabtagene Autoleucel Equecabtagene Autoleucel is an innovative fully human anti-BCMA CAR-T cell therapy which uses lentivirus as a gene vector to transfect autologous T cells. The CAR contains a fully human scFv, CD8a hinge and transmembrane, and 4-1BB co-stimulatory and CD3ζactivation domains. Based on rigorous molecular structure screening and comprehensive in vitro and in vivo functional evaluations, FUCASO demonstrates rapid and potent efficacy, accompanied by exceptional long-term persistence in vivo, enabling patients to achieve higher and deeper responses, providing continuous protection and care for patients with multiple myeloma. About IASO Bio IASO Bio Founded in 2017, IASO Bio is a leading biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of cutting-edge cell therapies and biologics. Initially focused on treatments for blood cancers, the company has strategically expanded into autoimmune diseases. IASO Bio boasts a robust drug development platform, encompassing early discovery to clinical trials, regulatory approval, and commercialization. The company is advancing a diverse pipeline of over 10 innovative products. Notably, Equecabtagene Autoleucel (FUCASO), the world’s first fully human CAR-T therapy developed by IASO Bio was approved by Chinese National Medical Products Administration (NMPA) in June 2023 for the treatment of relapsed and/or refractory multiple myeloma (R/R MM) who received ≥3 lines of prior therapies containing at least one proteasome inhibitor and an immunomodulatory agent. relapsed/refractory multiple myeloma (R/RMM) in patients at the fourth line and beyond. This product is also in Phase III clinical trials for second and third-line multiple myeloma (MM) and has received Investigational New Drug (IND) approvals in both China and US for autoimmune diseases. Meanwhile, the dual-target (CD19/CD22) product, CT120, for lymphoma is entering Phase II clinical trials. Additionally, RD118, another product targeting GPRC5D for the treatment of R/R MM, has received IND approval in China. In addition to CAR-T therapies, IASO Bio is advancing IASO-782, a fully human anti-CD19 monoclonal antibody. This product has secured IND approvals in China and USA for several autoimmune diseases, with plans to explore additional autoimmune indications. IASO Bio has established multiple global collaborations and licensing agreements with leading cell therapy companies, such as Sana Therapeutics, Cabaletta Bio, and Umoja Biopharma, underscoring its superior technology platform and commitment to next-generation cell therapies. With a strong management team, a robust pipeline, high-standard manufacturing and advanced clinical development capabilities, the company is well-positioned to drive innovation. It remains committed to accelerating the development of transformative therapies that address unmet medical needs for patients worldwide. For more information, please visit [http://www.iasobio.com](http://www.iasobio.com/) or [www.linkedin.com/company/iasobiotherapeutics](https://www.linkedin.com/company/iasobiotherapeutics). [Source link ](https://www.prnasia.com/story/archive/4652247_CN52247_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/powering-the-ai-revolution-investbanq-accelerates-digital-breakthrough-in-wealthtech/) ![Powering the AI Revolution: Investbanq Accelerates Digital Breakthrough in WealthTech](https://i0.wp.com/r2.thailandbusinessnews.net/2025/06/1749615775_image.jpg?resize=260%2C140&ssl=1 "Powering the AI Revolution: Investbanq Accelerates Digital Breakthrough in WealthTech") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Powering the AI Revolution: Investbanq Accelerates Digital Breakthrough in WealthTech SINGAPORE, June 11, 2025 /PRNewswire/ — Investbanq, the AI-powered wealth operating system… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - June 11, 2025 [](https://thailandbusinessnews.net/press-release/aixiner-revives-historic-spanish-textile-maker-nylstar-to-boost-global-reach/) ![Aixiner Revives Historic Spanish Textile Maker Nylstar to Boost Global Reach](https://i0.wp.com/r2.thailandbusinessnews.net/2025/11/1762994183_image.jpg?resize=260%2C140&ssl=1 "Aixiner Revives Historic Spanish Textile Maker Nylstar to Boost Global Reach") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Aixiner Revives Historic Spanish Textile Maker Nylstar to Boost Global Reach Acquisition of century-old nylon yarn specialist expands European footprint and strengthens integrated… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 13, 2025 [](https://thailandbusinessnews.net/press-release/brilliant-by-langham-unveils-brilliant-eats-an-exquisite-culinary-journey-and-exclusive-rewards-for-members/) ![BRILLIANT BY LANGHAM UNVEILS 'BRILLIANT EATS': AN EXQUISITE CULINARY JOURNEY AND EXCLUSIVE REWARDS FOR MEMBERS](https://i0.wp.com/r2.thailandbusinessnews.net/2024/11/BRILLIANT_BY_LANGHAM.jpg?resize=260%2C140&ssl=1 "BRILLIANT BY LANGHAM UNVEILS 'BRILLIANT EATS': AN EXQUISITE CULINARY JOURNEY AND EXCLUSIVE REWARDS FOR MEMBERS") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## BRILLIANT BY LANGHAM UNVEILS 'BRILLIANT EATS': AN EXQUISITE CULINARY JOURNEY AND EXCLUSIVE REWARDS FOR MEMBERS THE NEW CAMPAIGN PROVIDES MEMBER-ONLY ACCESS AND OFFERS TO UNIQUE DINING EXPERIENCES… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 28, 2024 ##### Most Read - [![OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/omnicom-media-was-awarded-3-3-billion-in-new-billings-in-h1-2026-more-than-any-other-global-media-group/ "OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP") [OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP](https://thailandbusinessnews.net/press-release/omnicom-media-was-awarded-3-3-billion-in-new-billings-in-h1-2026-more-than-any-other-global-media-group/ "OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP") - [![Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/green-empowerment-low-carbon-symbiosis-beijing-green-development-forum-2026-grandly-opens-at-beijing-municipal-administrative-center/ "Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center") [Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center](https://thailandbusinessnews.net/press-release/green-empowerment-low-carbon-symbiosis-beijing-green-development-forum-2026-grandly-opens-at-beijing-municipal-administrative-center/ "Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center") - [![China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/chinas-green-industries-take-center-stage-at-the-china-asean-expo-as-cooperation-in-energy-power-and-new-energy-vehicles-enters-a-new-phase/ "China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase") [China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase](https://thailandbusinessnews.net/press-release/chinas-green-industries-take-center-stage-at-the-china-asean-expo-as-cooperation-in-energy-power-and-new-energy-vehicles-enters-a-new-phase/ "China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase") - [![Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/hotel-shop-plus-2027-seamless-synergy-across-design-sustainability-digitalization/ "Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization") [Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization](https://thailandbusinessnews.net/press-release/hotel-shop-plus-2027-seamless-synergy-across-design-sustainability-digitalization/ "Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization") - [![Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/golden-week-2026-fuels-extended-breaks-and-new-travel-routes-trip-com-group-reveals-rising-destinations-and-regional-trends/ "Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends") [Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends](https://thailandbusinessnews.net/press-release/golden-week-2026-fuels-extended-breaks-and-new-travel-routes-trip-com-group-reveals-rising-destinations-and-regional-trends/ "Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends") - [![NYP launches Lumina to help students Go Beyond what they thought possible](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/nyp-launches-lumina-to-help-students-go-beyond-what-they-thought-possible/ "NYP launches Lumina to help students Go Beyond what they thought possible") [NYP launches Lumina to help students Go Beyond what they thought possible](https://thailandbusinessnews.net/press-release/nyp-launches-lumina-to-help-students-go-beyond-what-they-thought-possible/ "NYP launches Lumina to help students Go Beyond what they thought possible") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/china-eastern-airlines-launches-international-app-2-0-with-enhanced-digital-travel-services/) ![China Eastern Airlines Launches International App 2.0 with Enhanced Digital Travel Services](https://i0.wp.com/mmx.prnasia.com/media/MS1993575/a0bafa6b-dfb2-4d82-bf68-3a045915d48f.jpg?resize=260%2C140&ssl=1 "China Eastern Airlines Launches International App 2.0 with Enhanced Digital Travel Services") ## China Eastern Airlines Launches International App 2.0 with Enhanced Digital Travel Services SHANGHAI, Sept. 22, 2026 /PRNewswire/ — China Eastern Airlines (CEAir) recently… [](https://thailandbusinessnews.net/press-release/perform-ai-launches-ai-commerce-operating-system/) ![Perform.AI Launches AI Commerce Operating System](https://i0.wp.com/mmx.prnasia.com/media/MS1993622/IMG_5723-1.jpg?resize=260%2C140&ssl=1 "Perform.AI Launches AI Commerce Operating System") ## Perform.AI Launches AI Commerce Operating System Parcel Perform becomes Perform.AI for an industry where brands are chosen on… [](https://thailandbusinessnews.net/press-release/accesso-intelligence-introduces-agentic-ai-for-automated-workflows-in-visitor-attractions/) ## accesso® Intelligence Introduces Agentic AI for Automated Workflows in Visitor Attractions New capabilities help teams automate analysis, forecasting, reporting and work across… [](https://thailandbusinessnews.net/press-release/cambodias-national-destiny-project-construction-resumed-on-phase-ii-of-the-funan-techo-canal-aiming-to-reshape-the-indochina-peninsula/) ![Cambodia's National Destiny Project: Construction Resumed on Phase II of the Funan Techo Canal, Aiming to Reshape the Indochina Peninsula](https://i0.wp.com/mmx.prnasia.com/media/MS1993428/20260921220859EDT_image_1.jpg?resize=260%2C140&ssl=1 "Cambodia's National Destiny Project: Construction Resumed on Phase II of the Funan Techo Canal, Aiming to Reshape the Indochina Peninsula") ## Cambodia's National Destiny Project: Construction Resumed on Phase II of the Funan Techo Canal, Aiming to Reshape the Indochina Peninsula DOUN KAEV, Cambodia, Sept. 22, 2026 /PRNewswire/ — A news report from…